FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
METHOTREXATE SODIUM | 71335-1772-4 | Bryant Ranch Prepack | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 70518-3263-0 | REMEDYREPACK INC. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 70518-3263-4 | REMEDYREPACK INC. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 16729-486-36 | Accord Healthcare Inc. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 71335-1772-5 | Bryant Ranch Prepack | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 70518-3263-3 | REMEDYREPACK INC. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 71335-1772-7 | Bryant Ranch Prepack | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 16729-486-01 | Accord Healthcare Inc. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 71335-1772-8 | Bryant Ranch Prepack | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 70518-3263-1 | REMEDYREPACK INC. | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 42254-110-30 | Rebel Distributors Corp. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 66336-338-21 | Dispensing Solutions, Inc. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 66336-338-30 | Dispensing Solutions, Inc. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 75840-111-01 | GenPak Solutions LLC | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 75840-111-00 | GenPak Solutions LLC | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 61703-350-09 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 61703-350-10 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 61703-408-41 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 61703-124-40 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 61703-350-38 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 61703-408-25 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 61703-350-37 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-017-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-017-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-